The European Cystic Fibrosis Society Patient Registry: valuable lessons learned on how to sustain a disease registry

Por Viviani, Laura, Zolin, Anna, Mehta, Anil, Olesen, Hanne Vebert
Publicado em 2014

A multicentre, randomised intervention study of the Paediatric Early Warning Score: study protocol for a randomised controlled trial

Por Jensen, Claus Sixtus, Aagaard, Hanne, Olesen, Hanne Vebert, Kirkegaard, Hans
Publicado no Trials (2017)

Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis

Por Pedersen, Maya Graham, Jensen-Fangel, Søren, Olesen, Hanne Vebert, Tambe, San deep Prataprao, Petersen, Eskild
Publicado no BMC Infect Dis (2015)

Understanding the natural progression in %FEV(1) decline in patients with cystic fibrosis: a longitudinal study

Por Taylor-Robinson, David, Whitehead, Margaret, Diderichsen, Finn, Olesen, Hanne Vebert, Pressler, Tania, Smyth, Rosalind L, Diggle, Peter
Publicado em 2012

Exercise and quality of life in patients with cystic fibrosis: A 12-week intervention study

Por Schmidt, Anne Mette, Jacobsen, Ulla, Bregnballe, Vibeke, Olesen, Hanne Vebert, Ingemann-Hansen, Thorsten, Thastum, Mikael, Schietz, Peter Oluf
Publicado em 2011

Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis()

Por Qvist, Tavs, Taylor-Robinson, David, Waldmann, Elisabeth, Olesen, Hanne Vebert, Hansen, Christine Rønne, Mathiesen, Inger Hee, Høiby, Niels, Katzenstein, Terese L., Smyth, Rosalind L., Diggle, Peter J., Pressler, Tania
Publicado no J Cyst Fibros (2016)